Your browser doesn't support javascript.
loading
Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study.
Kim, Tae-Hwan; Kishimoto, Mitsumasa; Wei, James Cheng-Chung; Jeong, Haeyoun; Nozaki, Akiyo; Kobayashi, Shigeto.
Afiliación
  • Kim TH; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, The Republic of Korea.
  • Kishimoto M; Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Wei JC; Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Jeong H; Institute of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Nozaki A; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
  • Kobayashi S; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Rheumatology (Oxford) ; 62(5): 1851-1859, 2023 05 02.
Article en En | MEDLINE | ID: mdl-36130275
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Espondiloartritis Axial / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Espondiloartritis Axial / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article